تحميل...

A Comparison of Intramuscular and Subcutaneous Administration of LigA Subunit Vaccine Adjuvanted with Neutral Liposomal Formulation Containing Monophosphoryl Lipid A and QS21

Leptospirosis vaccines with higher potency and reduced adverse effects are needed for human use. The carboxyl terminal domain of leptospiral immunoglobulin like protein A (LigAc) is currently the most promising candidate antigen for leptospirosis subunit vaccine. However, LigAc-based vaccines were u...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Vaccines (Basel)
المؤلفون الرئيسيون:	Techawiwattanaboon, Teerasit, Barnier-Quer, Christophe, Palaga, Tanapat, Jacquet, Alain, Collin, Nicolas, Sangjun, Noppadon, Komanee, Pat, Patarakul, Kanitha
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI 2020
الموضوعات:	Article
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7565420/ https://ncbi.nlm.nih.gov/pubmed/32882903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8030494
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

A Comparison of Intramuscular and Subcutaneous Administration of LigA Subunit Vaccine Adjuvanted with Neutral Liposomal Formulation Containing Monophosphoryl Lipid A and QS21

مواد مشابهة